Press Release

Nitric Oxide-Based Therapies Treat Inflammatory Disorders, Cardiovascular Diseases, and Erectile Dysfunction

June 7th, 2010

Global Information Inc is pleased to announce a new market research report, "Nitric Oxide - Therapeutics, Markets and Companies" by Jain Pharmabiotech.

Nitric oxide is capable of both generating and scavenging free radicals. NO also functions as a signaling molecule and plays a vital role in the pathogenesis of several diseases. Nitric oxide delivery by various technologies represents a key area to focus on. Jain Pharmabtiotechs report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Current important therapeutic areas for NO-based therapies include: inflammatory disorders, cardiovascular diseases, erectile dysfunction, inflammation, pain and neuroprotection. According to the report, "the first therapeutic use of NO was by inhalation for acute respiratory distress syndrome (ARDS)." The report also compares NO-based therapies with conventional approaches and opportunities for combination with modern biotechnology approaches. Various pharmacological approaches are also described along with their therapeutic relevance. Additionally, "share of drugs where NO is involved in the mechanism of action is analyzed in the worldwide pharmaceutical market for 2009 and is projected to 2014 and 2019 as new drugs with NO-based mechanisms are introduced into the market. Various strategies for developing such drugs are discussed" as well.

Global Information Inc.(GII) - specializing in market research provision for the vertical industries, GII offers expert independent recommendations of publications from hundreds of the globe's leading market research firms.

Product Code : 70925